Data & APIs
Events
Cannabis
Marketfy
Premarket Prep

+

Create your free account

Already have an account? Login

Name:

Email Address:

Password:

Leave blank:

By creating an account, you agree to the
Terms of Service and acknowledge our Privacy Policy.

+

Log in to your account

Email Address:

Password:

Forgot your password?

Don't have a Benzinga account? Create one

Contribute
Login
Join

News
- Earnings
- Guidance
- Dividends
- M&A
- Buybacks
- Legal
- Interviews
- Management
- Retail Sales
- Offerings
- IPOs
- Insider Trades
- Biotech/FDA
- Freight
- Tech
Markets
- Pre-Market
- After Hours
- Movers
- ETFs
- Forex
- Cannabis
- Commodities
- Options
- Binary Options
- Bonds
- Futures
- Global Economics
- Previews
- Reviews
- Small-Cap
- Cryptocurrency
- Penny Stocks
Ratings
Ideas
Fintech
Investing
Cannabis
Education
Premium

Market Overview

Tickers, Articles and Keywords:

Tickers

Articles

Keywords

Search by keyword...

googlecse

More From
Summary
Ideas
Twitter ($)
All News
Analyst Coverage
Analyst Ratings
News Coverage
News
General
Contracts
Dividend Summaries
Dividend Calendar
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Press Releases
Earnings
Earning Summaries
Earnings Calendar
Guidance Summaries

Silverback Therapeutics, Inc. (SBTX)

48.01 +0.71 (1.50%)

Analyst Ratings

Find Analyst Ratings for:

Date	Research Firm	Action	Current	PT
12/29/20	SVB Leerink	Initiates Coverage On	Outperform
12/29/20	Stifel	Initiates Coverage On	Buy	58.0
12/29/20	HC Wainwright & Co.	Initiates Coverage On	Buy	44.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter

Recent Ratings

ARSSF (Downgrades)
EOLS (Downgrades)
WRB (Upgrades)
TRHC (Downgrades)
CTB (Downgrades)
BDRFF (Downgrades)
BIOVF (Downgrades)
KOS (Downgrades)
WBS (Downgrades)
STZHF (Upgrades)

News Coverage

6 Key Questions Apple Answered At The Annual Shareholder Event
Tesla's Swoon: Is Bitcoin The Tail Wagging The Dog?
Snapchat's 'Open-Ended Growth Story' Solidified After Analyst Day Event
BofA Raises Toyota Target Following News Of 2 EV Launches In 2021
KeyBanc Upgrades BigCommerce On Enterprise Momentum
Macau Lifts Coronavirus Travel Restrictions From Mainland China, Boosting Casino Stocks
DTCC Proposes Shortening US Trading Settlement Cycle To T+1: Here's Why That's Important
Square Analysts React To Q4 Earnings: 'Deceleration Somewhat Surprising'
Benzinga's Top Ratings Upgrades, Downgrades For February 24, 2021
10 Biggest Price Target Changes For Wednesday

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
News Widget
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Privacy Policy / Do Not Sell My Personal Data
Disclaimer
Service Status
Sitemap

© 2021 Benzinga | All Rights Reserved